Axis Labs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.45 M
- Revenue Growth -2.52%
- Profit Growth 74.67%
- Ebitda 9.32%
- Net Worth -0.41%
- Total Assets -39.88%
About Axis Labs
Axis Labs Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 January 2006 and has a history of 19 years and one month. Its registered office is in Delhi, Delhi.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.45 M.
Uttam Sagar and Rekha Sagar serve as directors at the Company.
Company Details
- Location Delhi, Delhi
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231DL2006PTC145340
- Company No.
145340
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jan 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Axis Labs Private Limited offer?
Axis Labs Private Limited offers a wide range of products and services, including Health Conditions, Fever, Kidney Care.
Who are the key members and board of directors at Axis Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uttam Sagar  | Director | 24-Jan-2006 | Current |
| Rekha Sagar | Director | 10-May-2022 | Current |
Financial Performance of Axis Labs.
Axis Labs Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.52% decrease. The company also saw a substantial improvement in profitability, with a 74.67% increase in profit. The company's net worth dipped by a decrease of 0.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Axis Labs?
In 2019, Axis Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.45 M
₹0
Charges Breakdown by Lending Institutions
- Capri Global Capital Limited : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2014 | Capri Global Capital Limited | ₹2.45 M | Open |
How Many Employees Work at Axis Labs?
Unlock and access historical data on people associated with Axis Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Axis Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axis Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
